-
Drug Price Disruptor Biotech Raises $500M in New Funds
A start-up biotechnology company that aims to bring drugs to market at lower cost is raising $500 million in its second venture funding round.
-
Infographic – Countries Making Covid-19 Vaccines
The U.S. and India are set to produce two-thirds of the world’s Covid-19 vaccine doses by the end of this year, presenting worldwide distribution challenges.
-
Digital Therapeutics Designed for Cancer/Covid-19 Stress
A digital health company is partnering with cancer advocacy organizations to provide electronic therapies to help patients deal with stresses from Covid-19.
-
Vaccine Shown Active Against New Covid-19 Variants
A current Covid-19 vaccine is shown in lab tests to produce antibodies that appear to protect against new mutations found in South Africa and the U.K.
-
CureVac, Bayer Partner on Covid-19 Vaccine Supply
Vaccine developer CureVac and global drug maker Bayer are partnering on further development, authorization, and supply of CureVac’s Covid-19 vaccine.
-
Protection from Legal Issues With These Core Hacks
These days more and more legal issues present themselves, and that’s why it is important to make sure you protect yourself.
-
Synthetic Biology Company Raises $105M in New Funds
A company developing cellular and genetic therapies for cancer designed like electronic circuits is raising $105 million in its second venture round.
-
Rocketing Sales for Your Small Company
If you are a small business owner, then you probably know that closing sales are crucial to your success.
-
Stem Cells Help Severe Covid-19 Cases Recover
Results of a clinical trial show stem cells from umbilical cord linings help patients with severe respiratory disease recover and survive from Covid-19 infections.
-
Synthetic Virus Company Forms, Raises $77M
A new biotechnology enterprise is underway that develops synthetic viruses attacking solid tumor cancers, based on research at the Salk Institute.